Elsevier Launches Malaria Nexus, Global Malaria Resource

New Online Knowledge Hub Aims to Become Leading Forum for Malaria Researchers, Editors and Opinion Leaders

OXFORD, England, August 11, 2010 - Elsevier, the world-leading publisher of scientific, technical and
medical information products and services, today announced the launch of
Malaria Nexus, Elsevier's Global Malaria Resource,
www.malarianexus.com.

Malaria Nexus highlights the latest published research in Malaria,
utilizing Elsevier's leading journals in Parasitology, Entomology and
Tropical Medicine, including The Lancet(R), The Lancet Infectious Diseases,
Transactions of the Royal Society of Tropical Medicine and Hygiene, and
International Journal for Parasitology.

"The aim of Malaria Nexus is to be a comprehensive resource and hub of
knowledge for malaria researchers worldwide" said Dale Seaton, Executive
Publisher for Parasitology, at Elsevier. "As well as making our latest
malaria publications free to download, we want to go beyond the article, and
become a leading forum for discussion between researchers, editors and
opinion leaders."

The site features interviews with key authors, who can expand on their
highlighted published work, as well as editors of some of Elsevier's most
prestigious journal titles. Active participation and feedback from interested
parties is encouraged. Currently featuring article feeds from 13 journals,
the site will include additional relevant journals over the coming months.

John Beier, Editor of the participating journal Acta Tropica, said, "From
remote settings in malaria endemic areas to sophisticated laboratories,
malaria researchers from around the world will certainly benefit from using
Malaria Nexus by reading timely highlights of first class publications,
learning the views of leading malaria experts, and expressing their important
opinions in this new forum for exchange of information."

For more information visit the site www.malarianexus.com and
register for updates.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus
(www.scopus.com), Reaxys (www.reaxys.com), MD Consult
(www.mdconsult.com) and Nursing Consult
(www.nursingconsult.com), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com) and
MEDai's Pinpoint Review (www.medai.com), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact

    Matthew Smaldon
    Group Marketing Communications Manager - Elsevier
    +44(0)1865-843644
    M.smaldon@elsevier.com

Media Contact: Matthew Smaldon, Group Marketing Communications Manager – Elsevier, +44(0)1865-843644, M.smaldon at elsevier.com .